Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence

NCT03082118 is registered in ClinicalTrials.gov with Solace Therapeutics, Inc. as lead sponsor.

NCT NCT03082118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03082118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vesair Continued Access Trial: Use of the Vesair® Bladder Control System in the Treatment of Post-Menopausal Female Subjects With Stress Urinary Incontinence
Lead sponsor
Solace Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 9, 2017
Completion date
January 15, 2019
Enrollment
7 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence